CD28 and cancer: The CD4+ T cells obtained from two different healthy donors were polyclonally stimulated with anti-CD3/CD28/CD2 moAb-coated beads and with IL-2 for 12 days, then subsequently polyclonally restimulated for next 3 days without IL-2 in the presence or without MDA-MB-231 cancer cells.